# IGC Pharma, Inc.: Form 8-K, filed Jan 13, 2021

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2021-01-13
- Accepted by EDGAR: Jan 13, 2021, 17:04 ET
- Period: 2021-01-13
- Accession: 0001185185-21-000077
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518521000077/indiaglob20210112_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518521000077/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518521000077/indiaglob20210112_8k.htm

Filed Jan 13, 2021.
Source: SEC EDGAR, the filing index for accession 0001185185-21-000077. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.
